Literature DB >> 16584116

Cytochrome P450s and other enzymes in drug metabolism and toxicity.

F Peter Guengerich1.   

Abstract

The cytochrome P450 (P450) enzymes are the major catalysts involved in the metabolism of drugs. Bioavailability and toxicity are 2 of the most common barriers in drug development today, and P450 and the conjugation enzymes can influence these effects. The toxicity of drugs can be considered in 5 contexts: on-target toxicity, hypersensitivity and immunological reactions, off-target pharmacology, bioactivation to reactive intermediates, and idiosyncratic drug reactions. The chemistry of bioactivation is reasonably well understood, but the mechanisms underlying biological responses are not. In the article we consider what fraction of drug toxicity actually involves metabolism, and we examine how species and human interindividual variations affect pharmacokinetics and toxicity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16584116      PMCID: PMC2751428          DOI: 10.1208/aapsj080112

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  51 in total

1.  Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo.

Authors:  D J Jollow; J R Mitchell; W Z Potter; D C Davis; J R Gillette; B B Brodie
Journal:  J Pharmacol Exp Ther       Date:  1973-10       Impact factor: 4.030

2.  Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide.

Authors:  S A Roberts; V F Price; D J Jollow
Journal:  Toxicol Appl Pharmacol       Date:  1990-09-01       Impact factor: 4.219

Review 3.  Glutathione conjugate mediated toxicities.

Authors:  T J Monks; M W Anders; W Dekant; J L Stevens; S S Lau; P J van Bladeren
Journal:  Toxicol Appl Pharmacol       Date:  1990-10       Impact factor: 4.219

4.  Progressive systemic sclerosis associated with exposure to trichloroethylene.

Authors:  J E Lockey; C R Kelly; G W Cannon; T V Colby; V Aldrich; G K Livingston
Journal:  J Occup Med       Date:  1987-06

5.  Metabolism of benzo(a)pyrene and benzo (a)pyrene derivatives to mutagenic products by highly purified hepatic microsomal enzymes.

Authors:  A W Wood; W Levin; A Y Lu; H Yagi; O Hernandez; D M Jerina; A H Conney
Journal:  J Biol Chem       Date:  1976-08-25       Impact factor: 5.157

6.  Anti-liver endoplasmic reticulum autoantibodies are directed against human cytochrome P-450IA2. A specific marker of dihydralazine-induced hepatitis.

Authors:  M Bourdi; D Larrey; J Nataf; J Bernuau; D Pessayre; M Iwasaki; F P Guengerich; P H Beaune
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

7.  Metabolic activation of pesticides with proestrogenic activity.

Authors:  D Kupfer; W H Bulger
Journal:  Fed Proc       Date:  1987-04

8.  The microsomal metabolism and site of covalent binding to protein of 3'-hydroxyacetanilide, a nonhepatotoxic positional isomer of acetaminophen.

Authors:  A J Streeter; S M Bjorge; D B Axworthy; S D Nelson; T A Baillie
Journal:  Drug Metab Dispos       Date:  1984 Sep-Oct       Impact factor: 3.922

9.  In vitro metabolism of methylene chloride in human and animal tissues: use in physiologically based pharmacokinetic models.

Authors:  R H Reitz; A L Mendrala; F P Guengerich
Journal:  Toxicol Appl Pharmacol       Date:  1989-02       Impact factor: 4.219

10.  Mechanism of the cardiotoxic actions of terfenadine.

Authors:  R L Woosley; Y Chen; J P Freiman; R A Gillis
Journal:  JAMA       Date:  1993 Mar 24-31       Impact factor: 56.272

View more
  130 in total

Review 1.  ADME of biologics-what have we learned from small molecules?

Authors:  Thomayant Prueksaritanont; Cuyue Tang
Journal:  AAPS J       Date:  2012-04-07       Impact factor: 4.009

2.  MS(M), an efficient workflow for metabolite identification using hybrid linear ion trap Orbitrap mass spectrometer.

Authors:  Robert Cho; Yingying Huang; Jae C Schwartz; Yan Chen; Timothy J Carlson; Ji Ma
Journal:  J Am Soc Mass Spectrom       Date:  2012-02-14       Impact factor: 3.109

Review 3.  P450 monooxygenases (P450ome) of the model white rot fungus Phanerochaete chrysosporium.

Authors:  Khajamohiddin Syed; Jagjit S Yadav
Journal:  Crit Rev Microbiol       Date:  2012-05-25       Impact factor: 7.624

4.  Characterization of 107 genomic DNA reference materials for CYP2D6, CYP2C19, CYP2C9, VKORC1, and UGT1A1: a GeT-RM and Association for Molecular Pathology collaborative project.

Authors:  Victoria M Pratt; Barbara Zehnbauer; Jean Amos Wilson; Ruth Baak; Nikolina Babic; Maria Bettinotti; Arlene Buller; Ken Butz; Matthew Campbell; Chris Civalier; Abdalla El-Badry; Daniel H Farkas; Elaine Lyon; Saptarshi Mandal; Jason McKinney; Kasinathan Muralidharan; LeAnne Noll; Tara Sander; Junaid Shabbeer; Chingying Smith; Milhan Telatar; Lorraine Toji; Anand Vairavan; Carlos Vance; Karen E Weck; Alan H B Wu; Kiang-Teck J Yeo; Markus Zeller; Lisa Kalman
Journal:  J Mol Diagn       Date:  2010-10-01       Impact factor: 5.568

Review 5.  Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.

Authors:  Enoche F Oga; Shuichi Sekine; Yoshihisa Shitara; Toshiharu Horie
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2016-04       Impact factor: 2.441

6.  Metabolic pathways of the camptothecin analog AR-67.

Authors:  Jamie Horn; Marta Milewska; Susanne M Arnold; Markos Leggas
Journal:  Drug Metab Dispos       Date:  2010-12-28       Impact factor: 3.922

7.  CYP2D6-CYP2C9 protein-protein interactions and isoform-selective effects on substrate binding and catalysis.

Authors:  Murali Subramanian; Michael Low; Charles W Locuson; Timothy S Tracy
Journal:  Drug Metab Dispos       Date:  2009-05-15       Impact factor: 3.922

8.  Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.

Authors:  Tatiana Y Hargrove; Zdzislaw Wawrzak; Paul W Alexander; Jason H Chaplin; Martine Keenan; Susan A Charman; Catherine J Perez; Michael R Waterman; Eric Chatelain; Galina I Lepesheva
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

Review 9.  Indolealkylamines: biotransformations and potential drug-drug interactions.

Authors:  Ai-Ming Yu
Journal:  AAPS J       Date:  2008-05-03       Impact factor: 4.009

10.  Synergistic metabolic toxicity screening using microsome/DNA electrochemiluminescent arrays and nanoreactors.

Authors:  Sadagopan Krishnan; Eli G Hvastkovs; Besnik Bajrami; Dharamainder Choudhary; John B Schenkman; James F Rusling
Journal:  Anal Chem       Date:  2008-06-19       Impact factor: 6.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.